Assyro AI

Orange Book product · Brand (NDA)

EZALLOR SPRINKLE

ROSUVASTATIN CALCIUM

Brand (NDA)NDA 208647DISCN SUN PHARM

At a glance

Dec 18, 2018

Approved

Brand (NDA)

Application

Not listed

TE code

1

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    Dec 18, 2018

    7 yr 7 mo ago

  2. Today

  3. Patent 10413543 expires

    Listed drug product patent expiration.

    Feb 12, 2036

    in 9 yr 10 mo

Pharmaceutical detail

Active ingredient

ROSUVASTATIN CALCIUM

Strength

EQ 5MG BASE

Dosage form

CAPSULE

Route

ORAL

TE code

Not listed

Application

NDA 208647

Product number

001

Marketing status

DISCN

Reference listed drug (RLD)

Yes

Reference standard (RS)

No

Active-ingredient family

View full family

This is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.

Listed patents (1)

Patents listed in the FDA Orange Book for this product, with expiration date and patent type.
PatentExpiresInType
10413543Feb 12, 2036in 9 yr 10 mo
Product
Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.